Probiotec Limited (ASX:PBP)


right-arrow Created with Sketch. -0.08 (-3.4%)
MCAP $191.1M
Last trade 16.10pm 25/01/2022 20mins delayed

Latest Announcements

17/12/2021PBPProbiotec Limited
17/12/2021PBPProbiotec Limited
08/12/2021PBPProbiotec Limited
06/12/2021PBPProbiotec Limited
02/12/2021PBPProbiotec Limited
30/11/2021PBPProbiotec Limited
30/11/2021PBPProbiotec Limited
30/11/2021PBPProbiotec Limited

Company Overview

Probiotec Limited is engaged in the development, manufacture, packing and sale of pharmaceuticals, consumer health and fast-moving consumer products in Australian and international markets. The Company owns approximately six manufacturing facilities in Australia and distributes its products both domestically and internationally. The Company’s products are manufactured on behalf of a range of clients, including international companies. It also owns Multipack-LJM business, a contract packer, providing packing services for a range of pharmaceutical, consumer healthcare, cosmetics and food, and beverage companies. The Company subsidiaries include Probiotec Pharmaceuticals Pty Ltd, Probiotec Pharma Pty Ltd, Biotech Pharmaceuticals Australia Pty Ltd, Biotech Pharmaceuticals Pty Ltd, Probiotec (NSW) Pty Ltd, Australian Dairy Proteins Pty Ltd, Milton Pharmaceuticals Pty Ltd and Willie Labs Generics Pty Ltd.

PBP in the news

Pharmaceutical product maker Probiotec (PBP) increased in value by more than a…
Probiotec has entered an agreement to sell the Celebrity Slim brand to…

Search Previous Announcements